🇺🇸 FDA
Patent

US 10814013

Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications

granted A61KA61K49/0002A61K49/06

Quick answer

US patent 10814013 (Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications) held by The Board of Regents of the University of Texas System expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K49/0002, A61K49/06, A61K51/0491, A61P